Organogenesis Holdings Inc.

NASDAQ:ORGO

3.19 (USD) • At close December 27, 2024
Bedrijfsnaam Organogenesis Holdings Inc.
Symbool ORGO
Munteenheid USD
Prijs 3.19
Beurswaarde 401,065,940
Dividendpercentage 0%
52-weken bereik 2.165 - 4.705
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Gary S. Gillheeney Sr.
Website https://organogenesis.com

An error occurred while fetching data.

Over Organogenesis Holdings Inc.

Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in

Vergelijkbare Aandelen

NanoString Technologies, Inc. logo

NanoString Technologies, Inc.

NSTG

0.105 USD

Alector, Inc. logo

Alector, Inc.

ALEC

1.78 USD

Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc.

KYMR

40.11 USD

Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

AVXL

12.11 USD

TransMedics Group, Inc. logo

TransMedics Group, Inc.

TMDX

61.02 USD

DocGo Inc. logo

DocGo Inc.

DCGO

4.38 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

32.53 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)